Curbside Consultation in Endoscopy: 49 Clinical Questions, Second Edition

Joseph Leung, MD; Simon Lo, MD

Question 7: What Is The Current Expert Opinion On What Hemostasis Technique To Use In Treating A Visible Vessel Or Dieulafoy Lesion? When Should I Involve A Surgeon? (continued)

Brintha K. Enestvedt, MD, MBA; Michael L. Kochman, MD, FACP

Advances in endoscopic therapy have greatly improved patient outcomes in the management of upper gastrointestinal (UGI) bleeding due to peptic ulcer disease and other UGI arterial lesions, such as Dieulafoy lesions. The prevalence of high-risk stigmata of bleeding for patients with peptic ulcers is approximately 5% to 10% for active arterial spurting and 20% to 25% for nonbleeding visible vessels (Figure 7-1). Endoscopic therapy reduces the rate of rebleeding from active arterial spurting from 80% to 90% (from medical therapy alone) to 15% to…